Drawing for ASOC

USPTO serial 97412977

ASOC

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
LINDEMYER, ANKHI MUKHERJEA
Law office
PETITIONS OFFICE

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with ASOC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $498*

Plus Government fees of $250

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jun-Hwa Jeong

Jun-Hwa Jeong RABIN & BERDO, P.C.2650 PARK TOWER DRIVE, SUITE 800VIENNA, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005Home virus test kits comprised primarily of a sterile nasal swab for medical purposes for selfsampling and also including a fluid collection tube with specimen preservation solution, printed registration instruction pamphlet for how to receive secure lab results delivery online, and overnight return plastic shipping bag for transmitting medical specimens, for lab-certified testing of bodily fluids for use in disease detection, namely, SARS-CoV-2, the virus that causes COVID-19; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, viral infections; Diagnostic test kits comprised of medical diagnostic reagents for medical purposes; Diagnostic test kits for medical use comprised of medical reagents for the diagnosis of genetic disease and cancer; Diagnostic kits comprised of medical reagents for the detection of microorganisms; Diagnostic kits comprised of medical diagnostic reagents for the detection of contagious infectionsACTIVE—
010Home virus test kits comprised of medical instruments, namely, lancets and saliva collection devices for medical purposes for taking biological samples for review and testing for various medical and genetic conditions; Medical test kits for diabetes monitoring for home use; Test kits comprised of blood glucose meter, lancets and testing strips for measuring blood glucose levels; Medical diagnostic apparatus for testing for viruses; Medical diagnostic apparatus for testing for bacteriaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 20, 2024PCBDPETITION TO DIRECTOR - CHANGE BASIS - DENIED—
Jun 17, 2024PILMPETITION INQUIRY LETTER ISSUED—
Jun 11, 2024APETASSIGNED TO PETITION STAFF—
May 6, 2024TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Nov 7, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 23, 2023DOCKASSIGNED TO EXAMINER—
Sep 12, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 12, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 23, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 8, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jul 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 12, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 30, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 15, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 8, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2023DOCKASSIGNED TO EXAMINER—
May 24, 2022MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 23, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 19, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance